'Primary end' diaporamas de présentation

Preventive Maintenance Schedules

Preventive Maintenance Schedules. ROLE OF C&W ORGANISATION To Provide Coaches & Wagon In Good Fettle To Traffic To Keep In Good Fettle Requires Maintenance. MAINTENANCE Break Down Maintenance Fail & Fix Preventive Maintenance Periodic Maintenance Attention at Specific Interval

1.13k views • 66 slides

The Rationale for Therapeutic Plasma Exchange

1.07k views • 56 slides

Injuries to the Chest

Injuries to the Chest. Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee. Initial Evaluation and Management. Primary Survey. Organized and rapid Aimed at recognizing and treating immediately life-threatening problems

758 views • 53 slides

Heinz Ludwig Department of Medicine I Center for Oncology, Hematology and Palliative Care

Heinz Ludwig Department of Medicine I Center for Oncology, Hematology and Palliative Care Wilhelminenhospital, Vienna, Austria. What we know about myeloma in elderly patients from trials and observational studies?. Goals of therapy in elderly patients. Drug combinations for elderly patients.

734 views • 53 slides

Bifurcation PCI and UK Trial Update

Bifurcation PCI and UK Trial Update. Rosie Swallow Royal Bournemouth Hospital. No conflicts of interest. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions. The Nordic Bifurcation Study . Circulation . 2006;114: 1955-1961. Background.

778 views • 47 slides

Traitements non Antibiotiques du Choc Septique

673 views • 43 slides

New treatment approaches in Hepatocellular Carcinoma

New treatment approaches in Hepatocellular Carcinoma. Dr. Francesco Caponigro Istituto Tumori Napoli. Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death and the fifth most prevalent cancer worldwide with > 80% of patients presenting with advanced disease.

1.09k views • 42 slides

674 views • 39 slides

Enrico Romagnoli

Comparison of Coronary Artery Bypass Surgery versus Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients with Chronic Kidney Disease. Enrico Romagnoli. Interventional Cardiology Unit Policlinico Casilino , Rome, Italy enromagnoli@gmail.com. Background I.

714 views • 32 slides

CARE: Effect of Lipid Lowering on Lipid Values and Coronary Events in CHD Patients With Average Cholesterol

502 views • 31 slides

University of Nebraska Medical Center, Omaha, NE

Prospective Randomized Comparison of Conventional Stress Echocardiography with Real Time Perfusion Stress Echocardiography in Predicting Clinical Outcome . University of Nebraska Medical Center, Omaha, NE. Disclosure. Thomas R Porter, MD has the following conflict of interests to disclose:

416 views • 31 slides

A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial

Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation . A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial . Seung-Jung Park, MD, PhD, University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial .

768 views • 30 slides

Done By : Dina AL-Badawi Reham AL-Hazmi Pharm.D candidates

Done By : Dina AL-Badawi Reham AL-Hazmi Pharm.D candidates. The primary Objective of IDEAL. In stable CHD patients. LDL-C Simvastatin 20-40 mg/d Atorvastatin 80 mg/d

464 views • 28 slides

BACKGROUND

Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and meta-analysis.

274 views • 13 slides

first line treatment maintenance/consolidation treatment of recurrent disease

WHAT WILL THE KEY ISSUES IN END-POINT ASSESSMENT BE, IN FUTURE OVARIAN CANCER TRIALS INVOLVING NOVEL TARGETED AGENTS?. first line treatment maintenance/consolidation treatment of recurrent disease. Prof. S.B. Kaye Royal Marsden Hospital London. GCIG Orlando 2009.

230 views • 12 slides

Is ticagrelor superior to prasugrel for the treatment of acute coronary syndromes? Evidence from a 32,893-patient adjust

Is ticagrelor superior to prasugrel for the treatment of acute coronary syndromes? Evidence from a 32,893-patient adjusted indirect comparison meta-analysis. Giuseppe Biondi-Zoccai gbiondizoccai@gmail.com Division of Cardiology, University of Turin, Turin, Italy . Background.

561 views • 11 slides

Mean change from baseline in glycated hemoglobin over time after alogliptin vs. placebo

267 views • 2 slides